ReCellTis Wound Cream is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Cellnovation Technology. The primary component is Lidocaine; Polymyxin B Sulfate; Bacitracin Zinc; Neomycin Sulfate.
| Product ID | 71929-070_8902aa55-547e-787f-e053-2a95a90a2289 |
| NDC | 71929-070 |
| Product Type | Human Otc Drug |
| Proprietary Name | ReCellTis Wound Cream |
| Generic Name | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Lidocaine Hcl |
| Dosage Form | Cream |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2019-06-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part333B |
| Labeler Name | CellNovation Technology |
| Substance Name | LIDOCAINE; POLYMYXIN B SULFATE; BACITRACIN ZINC; NEOMYCIN SULFATE |
| Active Ingredient Strength | 600 mg/30g; [USP'U]/30g; [USP'U]/30g; mg/30g |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-10-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part333B |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2019-10-01 |
| Ingredient | Strength |
|---|---|
| LIDOCAINE | 600 mg/30g |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 71929-069 | ReCellTis | bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl |
| 71929-070 | ReCellTis | bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RECELLTIS 90364383 not registered Live/Pending |
CellNovation Technology Corporation 2020-12-07 |
![]() RECELLTIS 87562289 not registered Dead/Abandoned |
MRI Enterprises, LLC 2017-08-09 |